Showing results (651-660 of 1,153) with videos related to

Sort By:
Pageof 116
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
International Journal of Molecular Sciences|October 14, 2023
Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced ObesityJudith Sommer, Hanna Ehnis, Tatjana Seitz, et al.
Diabetes|June 21, 2014
GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose loweringFlorian Kahles, Christina Meyer, Julia Möllmann, et al.
Plos One|September 13, 2014
Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseasesLisa Frehn, Anke Jansen, Eveline Bennek, et al.
Scientific Reports|December 16, 2017
Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formationManuel Brehs, André J G Pötgens, Julia Steitz, et al.
Plos Pathogens|May 29, 2015
Ly6C- Monocytes Regulate Parasite-Induced Liver Inflammation by Inducing the Differentiation of Pathogenic Ly6C+ Monocytes into MacrophagesYannick Morias, Chloé Abels, Damya Laoui, et al.
Zeitschrift Fur Gastroenterologie|October 20, 2021
[The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment]Arndt Vogel, Martina Sterneck, Florian Vondran, et al.
Hepatology (Baltimore, Md.)|May 19, 2017
Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in miceJörg-Martin Bangen, Linda Hammerich, Roland Sonntag, et al.
Plos One|March 5, 2015
Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosisBastian Höchst, Julita Mikulec, Tania Baccega, et al.
Mediators of Inflammation|August 25, 2020
Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-UpLukas Buendgens, Eray Yagmur, Axel Ginsberg, et al.
Pageof 116